Telyrx Holdings Inc

TelyRx Holdings, Inc. operates as a capital pool company. The company is headquartered in Toronto, Ontario. The company went IPO on 2025-10-24. Connecting patients with independent, state-licensed providers to access over 350 everyday medications across 48 states and territories in the United States, the Company fulfills prescriptions through licensed retail pharmacies in Florida and Texas, delivering medication directly. The firm's product categories include flu and infections, chronic conditions, digestive and travel, skin and hair, women's health, men's health, lifestyle, weight loss, doctor's notes, pets, and supplements. The firm's chronic conditions product categories include allergies, asthma, diabetes, dry eye, gingivitis, glaucoma, high cholesterol, and migraine. The firm's flu and infections product categories include anti-fungal, cold and flu, cold sores, ear and eye infections and herpes. Its doctor's notes product categories include excuse note and emotional support animal letter.